pyrimidoindole derivatives agonists human hematopoietic stem cell self-renewal 
small number hematopoietic stem progenitor cells cord blood units limits widespread use human transplant protocols identified family chemically related small molecules stimulates expansion ex vivo human cord blood cells capable reconstituting human hematopoiesis least months immunocompromised mice potent activity newly identified compounds um171 prototype independent suppression aryl hydrocarbon receptor targets cells more-limited regenerative potential properties um171 make potential candidate hematopoietic stem cell transplantation gene therapy 
